Here, we show that activation of the checkpoint effector kinase Chk1 in response to irradiation-induced DNA damage is minimal in G1, maximal during S-phase and diminishes as cells enter G2. In addition, formation of irradiation-induced replication protein A (RPA)-coated single-stranded DNA (RPA-ssDNA), a structure required for ATM and Rad3-related (ATR)-Chk1 activation, occurs in a broadly similar pattern. Cyclin-dependent kinase (Cdk) activity is thought to promote RPA-ssDNA formation by stimulating DNA strand resection at doublestrand breaks (DSBs), providing one possible mechanism of imposing cell cycle dependence on DNA damage signaling. However, it has recently been shown that Chk1 itself is also subject to Cdk-mediated phosphorylation at serines 286 and 301 (S286 and 301). We show that Chk1 S301 phosphorylation increases as cells progress through S and G2 and that both Cdk1 and Cdk2 are likely to contribute to this modification in vivo. We also find that substitution of S286 and S301 with non-phosphorylatable alanine residues strongly attenuates DNA damage-induced Chk1 activation and G2 checkpoint proficiency, but does not eliminate the underlying cell cycle dependence of Chk1 regulation. Taken together, these data indicate that Cdk activity regulates multiple steps in the DNA damage response pathway including full activation of Chk1 and checkpoint proficiency.
Introduction
In eukaryotes DNA double-strand breaks (DSBs) can be repaired via two main mechanisms: non-homologous end-joining and homologous recombination repair (HRR) (Sancar et al., 2004; Helleday et al., 2007) . Non-homologous end-joining can occur throughout the cell cycle, however, because HRR requires a sister chromatid to serve as a template, this mechanism is utilized preferentially in the S and G2 phases when chromosome duplication is ongoing or complete. Unlike non-homologous endjoining, HRR requires extensive DNA damage processing to generate tracts of single-stranded DNA (ssDNA) which, once coated with Rad51 recombinase, invade the homologous DNA duplex to initiate repair (Sung and Klein, 2006; San Filippo et al., 2008) . It is well established in yeasts that cyclin-dependent kinases (Cdks) have a major role in controlling DNA strand resection (Wohlbold and Fisher, 2009; Yata and Esashi, 2009) . A recently identified Cdk target involved in DNA strand resection at DSBs is Sae2, a homolog of CtIP in vertebrates and Ctp1 in fission yeast. Cdk-dependent phosphorylation of Sae2 at Ser267 is needed for proper DNA end-resection and HRR (Huertas et al., 2008) . In mammalian cells, Cdks have a role in DSB resection via CtIP. Cdk2 phosphorylates CtIP on Ser327 and Thr847 during S and G2 phases, modifications that have been shown to stimulate interaction with BRCA1 to promote DSB resection (Yu and Chen, 2004; Huertas and Jackson, 2009) .
In metazoans, most of the evidence that Cdks have a role in DSB resection relies on the use of broad-range Cdk inhibitors. It remains unclear which Cdk/cyclin complexes perform functions analogous to budding yeast Cdc28/clb. Cyclin A/Cdk2 is the major Cdk complex from late G1, through S phase to early G2 in human cells. Results from Cdk2-/-mice and Cdk2-/-MEFs show increased sensitivity to radiation-induced DSBs and delayed DNA repair (Satyanarayana et al., 2008) . In human U2OS osteosarcoma cells, irradiationinduced replication protein A (RPA)-coated ssDNA formation and Chk1 S345 phosphorylation are sensitive to roscovitine and coincide with cyclin A expression, implicating mammalian Cdk2 in the regulation of DSB resection and HRR (Jazayeri et al., 2006) . However, a recent study using MEFs genetically modified to lack various combinations of interphase Cdks together with Cdk inhibitor drugs concluded that DNA damage response is controlled by the overall level of Cdk activity rather than by specific individual Cdks (Cerqueira et al., 2009).
Although Cdk-dependent DNA strand resection has a role in restricting both HRR and ATM and Rad3-related (ATR)-Chk1 activation to specific phases of the cell cycle (Jazayeri et al., 2006) , other mechanisms may contribute, and interestingly, Chk1 itself is also a Cdk target. Chk1 can be phosphorylated at serines 286 and 301 (S286 and S301) by Cdk1 during mitosis (Shiromizu et al., 2006) . Mitotic hyper-phosphorylation of Chk1 seems to promote translocation from the nucleus to the cytoplasm in prophase, thus releasing an inhibitory effect of Chk1 on Cdk1 to promote rapid mitotic entry (Enomoto et al., 2009) . It might also modulate Chk1 association with the centrosome, where Cdk1 activation begins (Kramer et al., 2004) . Conversely, Chk1 S286 and S301 phosphorylation can also be induced under stress conditions, such as hydroxyurea or UV, when entry to mitosis is blocked by checkpoint activation. Cdk2 was shown to have the potential to catalyze S286/S301 phosphorylation in vitro (Ikegami et al., 2008) , although whether this occurred in vivo was not established. In addition, the occurrence and functional significance of Chk1 S286/S301 phosphorylation during interphase during unperturbed cell cycles was not determined (Ikegami et al., 2008) .
Here, we investigate the cell cycle dependency of Chk1 activation and RPA-coated ssDNA formation in response to irradiation at the single cell level using centrifugal elutriation and S-phase labeling to precisely identify individual cells in G1, S and G2 phase. We also document cell cycle regulation of Cdk-mediated phosphorylation of Chk1 during interphase, provide evidence that both Cdk1 and Cdk2 contribute to this modification in vivo, and finally show that Cdk-mediated phosphorylation is important for efficient Chk1 activation and optimal checkpoint proficiency in response to DNA damage.
Results
Chk1 activation in response to DNA damage is minimal in G1, maximal in S phase, and declines again and G2 Previously, we found that irradiation-induced Chk1 activation varies according to cell cycle position using elutriation (Walker et al., 2009; Xu et al., 2010) , however, this approach did not allow comparison of levels of activation specifically in G1, S and G2/M phase. To refine this analysis, we examined the relationship between cell cycle position and Chk1 activation in individual cells. DT40 cells enriched in G1/early S phase (F1) or late S/ G2/M (F2) were prepared by elutriation ( Supplementary  Figure 1) , returned to culture and immediately labeled with 5-ethynyl-2-deoxyuridine (EdU) for 30 min to identify the replicating cells in each fraction. A portion of each fraction was then irradiated to induce DNA damage or treated with aphidicolin to inhibit DNA synthesis. After a further 30 min, cells were fixed and costained for EdU and Chk1 phosphorylated at serine 345 (S345P) (Supplementary Figure 1) . The Chk1 S345P signal intensity was then quantified in individual cells using EdU staining to discriminate G1 from early S and G2 from late S phase. As shown in Figure 1a , the basal level of S345P Chk1 in untreated cells was very low, although S phase cells (F1 and F2 combined) showed measurably stronger staining. In comparison, irradiationinduced Chk1 S345 phosphorylation in all phases of the cell cycle but to varying extents: activation was weakest (but nevertheless detectable) in G1 cells, maximal in Sphase cells, and substantially lower again in G2 cells. As reported previously (Walker et al., 2009) , aphidicolin stimulated Chk1 S345 phosphorylation very strongly, however, this activation was confined to S phase cells with little, if any, detectable increase in G1 or G2 (Supplementary Figure 1) .
DNA damage processing is cell cycle regulated It has been reported previously that DNA strand resection at DSBs is restricted to S and G2 phase and Figure 1) were labeled for 30 min with EdU, exposed to 10 Gy IR, and after a further 30 min fixed and processed for EdU and anti-Chk1 S345P staining. Shown is the mean and s.e. from three independent experiments. (b) Quantification of RPA focus formation in individual G1, S and G2 cells in elutriated fractions determined by confocal immunofluorescence analysis. Elutriated fractions of DT40 cells as in (a) were labeled for 30 min with EdU, and then exposed to 10 Gy IR. After a further 30-min incubation, cells were fixed and processed for EdU and anti-RPA staining (as shown in Supplementary Figure 2) . Shown is the mean and s.e. from three independent experiments.
Cdk phosphorylation regulates Chk1 activation N Xu et al that Cdk activity has a major role in controlling damage processing (Huertas et al., 2008; Wohlbold and Fisher, 2009) . As a result of its central role in initiating both checkpoint signaling (via ATR activation) and DNA repair by homologous recombination, we postulated that DNA damage-induced strand resection might exhibit a similar pattern of cell cycle regulation to Chk1 activation. To investigate this, we examined the relationship between cell cycle position and formation of tracts of RPA-coated ssDNA in individual cells after irradiation by combining EdU labeling and immunofluorescence using antibodies specific for RPA.
As shown in Supplementary Figure 2 , irradiation induced a marked concentration of RPA in nuclear foci in both EdU-positive and -negative cells in asynchronous cells and in the F1/F2 fractions. Quantification of these data (Figure 1b) revealed that the basal level of RPA staining in untreated cells was low, although S phase cells showed slightly stronger staining. As with Chk1 S345 phosphorylation, irradiation-induced RPA focus formation in all phases of the cell cycle but the induced levels were again highest in S-phase (Figure 2b ). The finding that irradiation-induced RPA focus formation in G1 cells seems contradictory to a previous report that formation of DSB-induced RPA foci was confined to the S and G2 phases of the cell cycle using cyclin A to identify S and G2 phase cells (Jazayeri et al., 2006) . This apparent discrepancy could be due to the different techniques used to discriminate cells in different cell cycle stages. Our study combined EdU staining, centrifugal elutriation and flow cytometry to unambiguously identify individual G1, S and G2 phase cells. Alternatively, cell type-specific differences in the regulation of DNA damage processing could also be a factor. , Cdk2-/-and Cdk1as/Cdk2-/-cells were pretreated for 2 h with either 1NM-PP1 or roscovitine before 10 Gy IR. At 30 min after irradiation, cell extracts were prepared and analyzed by western blotting using the indicated antibodies. Note that the exogenous Cdk1as mutant protein is overexpressed compared with endogenous Cdk1 in Cdk2-/-cells.
Cdk phosphorylation regulates Chk1 activation N Xu et al
Both Cdk1 and Cdk2 contribute to Chk1 S301 phosphorylation in vivo Previous studies have provided evidence that Chk1 can be phosphorylated at S286 and S301 by both Cdk1 and Cdk2 in vitro, and that modification of these residues is observed both during mitosis and under conditions of DNA damage and replication stress (Shiromizu et al., 2006; Ikegami et al., 2008) . The potential role of Cdkmediated Chk1 phosphorylation during checkpoint activation in vivo, however, remains unclear. S301 is conserved in human, mouse and avian Chk1, therefore we generated a phospho-specific rabbit polyclonal antibody specific for Chk1 phosphorylated at S301 (a-S301P; see Materials and methods section for details).
The phospho-specificity of the resulting antibody was established by pre-incubation with either phosphorylated or non-phosphorylated peptide before western blotting ( Figure 2a ). As previously reported (Ikegami et al., 2008) , treatment with the DNA replication inhibitor aphidicolin or the spindle poison nocodazole stimulated Chk1 S301 phosphorylation (Figure 2a ), while immunofluorescence analysis using a-S301P antibody revealed that Chk1 phosphorylated at this site was predominantly nuclear in interphase cells (Figure 2b ). To determine whether Chk1 S301 phosphorylation fluctuates during an unperturbed cell cycle, we used centrifugal elutriation to separate asynchronous DT40 cultures into six fractions enriched in specific cell cycle phases as described previously (Walker et al., 2009) . Fraction 1 (F1) contained predominantly G1 phase cells (G1 ¼ 72%), F4 almost exclusively S phase (S ¼ 86%), whereas G2/M phase cells were highly enriched (69%) in F6. Cell extracts were prepared from purified fractions and analyzed for Chk1 S301 phosphorylation by western blotting. As shown in Figure 2c , Chk1 S301P was almost undetectable in F1 and very weak in F2, but started to increase in F3 and reached a peak in F6. Even higher levels were observed in a nocodazole-treated (ND) culture, where approximately 60% of cells were mitotic. Thus, Chk1 S301 phosphorylation increases as cells progress through the cell cycle with the highest levels observed in S and G2/M phase cells, consistent with the idea that it might be catalyzed by both Cdk1 and Cdk2 (Shiromizu et al., 2006; Ikegami et al., 2008) .
To further investigate the role of Cdk1 and Cdk2 in mediating Chk1 phosphorylation in unperturbed cells or checkpoint activated cells, we utilized three genetically modified DT40 cell lines. In two of these cell lines, an analogue-sensitive mutant of Cdk1 (Cdk1as), which is selectively sensitive to the ATP analogue inhibitor 1NM-PP1 (Hochegger et al., 2007) , replaces endogenous Cdk1 either in the presence (Cdk1as) or absence of endogenous Cdk2 (Cdk1as/Cdk2-/-). For comparison, we also included Cdk2-knockout cells (Cdk2-/-) that retain endogenous Cdk1 (Hochegger et al., 2007) . It has been shown previously that the exogenous Cdk1as mutant protein is expressed at higher levels than endogenous Cdk1 (Hochegger et al., 2007) . It is nevertheless believed that either the endogenous or exogenous analogue-sensitive mutant Cdk1 proteins substitute for endogenous Cdk2 in the single Cdk2-/-and double mutant Cdk1as/Cdk2-/-cells, respectively (Hochegger et al., 2007) .
We pretreated asynchronous Cdk1as and Cdk1as/ Cdk2-/-cells for two hours with either 1NM-PP1 or roscovitine, a cell permeable pan-Cdk inhibitor, before irradiation then analyzed the phosphorylation status of Chk1 S301 and S345 by western blotting. Strikingly, the basal level of Chk1 S301P was completely inhibited by both 1NM-PP1 and roscovitine in Cdk1as/Cdk2-/-cells (Figure 2d) , where the analogue-sensitive Cdk1as mutant protein is thought to fulfill both Cdk1 and Cdk2 functions. In comparison, 1NM-PP1 had no effect on the basal level of Chk1 pS301 in either Cdk1as or Cdk2-/-cells where endogenous Cdk2 or Cdk1 are present respectively, whereas roscovitine was significantly inhibitory in all three cell lines. Taken together, these data suggest that both Cdk1 and Cdk2 contribute to the basal level of Chk1 S301 phosphorylation in unperturbed proliferating cells.
The effect of 1NM-PP1 and roscovitine on DNA damage-induced Chk1 activation was also examined by analyzing the phosphorylation of S345. As shown in Figure 2d , irradiation-induced Chk1 S345 phosphorylation was significantly inhibited by both 1NM-PP1 and roscovitine in Cdk1as/Cdk2-/-double mutant cells. In comparison, 1NM-PP1 had little or no effect on irradiationinduced Chk1 S345 phosphorylation in either Cdk1as or Cdk2-/-cells whereas roscovitine was significantly inhibitory in both. These results are consistent with the recent suggestion that the DNA damage response can be regulated by the overall level of Cdk activity rather than by specific Cdks (Cerqueira et al., 2009) . In contrast to irradiation, neither 1NM-PP1 nor roscovitine significantly inhibited Chk1 S345 phosphorylation in response to DNA synthesis inhibition by aphidicolin treatment in Cdk1as or Cdk2-/-cells, although modest attenuation was observed in Cdk1as/ Cdk2-/-double mutant cells with both drugs (Supplementary Figure 3 ). This suggests that Cdk activity may also influence Chk1 activation in response to stalled replication forks as well as to irradiation-induced DNA damage.
Cdk-mediated phosphorylation of Chk1 S286/301 is required for efficient activation by DNA damage but not for cell cycle-dependent regulation As shown in Figure 1a , irradiation-induced Chk1 S345 phosphorylation is strongly cell cycle-dependent. The finding that Cdk-mediated phosphorylation of Chk1 also fluctuates as cells progress through the cell cycle (Figure 2c ) raised the issue of whether this modification contributes to the cell cycle-dependent regulation of Chk1. To gain insight into the functional significance of Cdk-mediated Chk1 phosphorylation, we stably reconstituted Chk1-deficient DT40 cells with a mutant form of Chk1 in which both of the known Cdk phosphorylation residues, S286 and S301, were replaced by alanine residues. Then, we compared the relationship between cell cycle position and Chk1 activation in individual DT40 S2A (Chk1 S286A/S301A) mutant cells using the same single cell approach shown in Figure 1 . Chk1-deficient cells reconstituted with wild-type Chk1 (DT40 Rev) were used for comparison.
As shown in Figure 3a , irradiation-induced Chk1 S345 phosphorylation in a cell cycle-dependent manner in DT40 S2A mutant cells; activation was weakest in G1 cells, maximal in S phase cells and lower again in G2 cells. However, the absolute levels of S345 phosphorylation were in each case significantly lower in the Chk1 S2A mutant protein compared with wild-type Chk1, suggesting that Cdk phosphorylation is required for efficient Chk1 activation. This was confirmed by western blotting analysis, which revealed that the stoichiometry of S345 phosphorylation within the Chk1 S2A mutant protein was greatly reduced compared with wild-type Chk1 in both DT40 and DT40 Rev cells after irradiation (Figure 3b, upper panel) . Similar results were observed when DT40, DT40 Rev and DT40 S2A cells were treated with camptothecin or etoposide, indicating that Cdk-mediated phosphorylation of Chk1 S286/301 is required for efficient activation in response to diverse genotoxic stresses (Figure 3b, lower panels) .
To confirm that DNA damage-induced S345 phosphorylation of the Chk1 S2A mutant remained cell cycle dependent by an independent means, we fractionated DT40 S2A or DT40 Rev cells by elutriation (as shown in Figure 2c ) with or without previous irradiation and analyzed Chk1 S345P levels by western blotting. As shown in Figure 4a , irradiation-induced S345 phosphorylation of the Chk1 S2A mutant protein showed a similar qualitative pattern of regulation to wild-type Chk1, consistent with the single cell analysis shown in Figure 3a . We attribute this to continued cell cycledependent regulation of upstream DNA damage processing and ATR activation, because the extent and pattern of irradiation-induced RPA focus formation was similar in individual DT40 S2A and DT40 Rev cells (Figure 4b ). Interestingly, irradiation had little effect on the level of Cdk-mediated Chk1 S301 phosphorylation in DT40 Rev cells (Figure 4a ). This was somewhat unexpected, since inhibition of Cdk1 activity is a well-established downstream target of the G2 checkpoint mechanism that occurs rapidly after DNA damage (O'Connell et al., 2000) . One likely explanation lies in the recent discovery that Cdk2 activity, unlike Cdk1, is resistant to inhibition and persists after irradiation in DT40 cells (Bourke et al., 2010) .
Cdk phosphorylation of Chk1 S286/301 is required for optimal checkpoint proficiency ATR-mediated phosphorylation of S345 has been shown to be crucial for both biochemical activation of Chk1 and checkpoint proficiency (Niida et al., 2007; Walker et al., 2009) . The finding that S345 phosphorylation of the Chk1 S2A mutant protein was impaired compared with wild-type after DNA damage raised the Cdk phosphorylation regulates Chk1 activation N Xu et al question of whether its biological function was similarly affected. To test this, we determined whether the Chk1 S2A mutant protein could complement the G2 DNA damage checkpoint defect when stably reintroduced into Chk1-deficient DT40 cells . To quantify G2 checkpoint proficiency, wild-type DT40, DT40 Chk1-/-, DT40 Chk1 Rev and DT40 Chk1 S2A cells were incubated with nocodozole for 10 h with or without previous irradiation and the percentage of phospho-S10 histone H3-positive (mitotic) cells was determined by flow cytometry. As shown in Figure 5a , irradiation induced an 80% reduction in the number of wild-type DT40 cells accumulating in mitosis (IR þ ND, black bar) compared with nocodazole alone (ND, white bar). This G2 checkpoint arrest is completely absent in DT40 Chk1-/-cells, but is substantially restored upon stable re-expression of wild-type Chk1 in DT40 Rev cells. In comparison, the Chk1 S2A mutant was significantly compromised in its ability to restore G2 checkpoint proficiency, with Cdk phosphorylation regulates Chk1 activation N Xu et al only a 40% reduction in the number of mitotic cells accumulating after irradiation compared with nocodazole alone (Figure 5a ). The Chk1 S2A mutant protein was expressed at slightly lower levels than wild-type Chk1 in DT40 Rev cells (Figure 5b ), however, we have shown using a conditional expression system that small fluctuations in wild-type Chk1 levels have no impact on checkpoint proficiency in complemented cells (Walker et al., 2009; Supplementary Figure 4) . We deduce therefore that Chk1 S2A is intrinsically impaired for both activation and checkpoint function.
Maintenance of inhibitory tyrosine 15 (Y15) phosphorylation of Cdk1 is an important downstream target of Chk1 during G2 checkpoint activation (O'Connell et al., 2000) and, consistent with this, Cdk1 Y15 levels increased in response to irradiation in WT DT40 and DT40 Rev cells, but not in DT40 Chk1-/-or DT40 S2A cells (Figure 5b ). To determine whether the impaired activation and function of the Chk1 S2A mutant protein might be attributable to altered subcellular localization, we fused wild-type Chk1 and Chk1 S2A to green fluorescent protein (GFP) and stably expressed the resulting proteins in Chk1-deficient cells. As shown in Figure 5c , both GFP-Chk1 wild-type and GFP-Chk1 S2A were predominantly nuclear.
Discussion
Recent studies have shown that activation of the ATRChk1 pathway in response to DSBs increases as cell progress through the cell cycle (Jazayeri et al., 2006; Walker et al., 2009; Xu et al., 2010) . By analyzing ATRmediated Chk1 S345 phosphorylation in individual DT40 cells at defined points in the cell cycle, we find that the situation is more complex than simple restriction of DNA damage-induced ATR-Chk1 activation to the later S and G2 phases when Cdk activity is high (Jazayeri et al., 2006) . Rather, we find that Chk1 activation can be elicited throughout interphase but to markedly varying extents; activation is weakest in G1 phase, maximal in S phase and lower again in G2 phase (Figure 1a) .
Although the processes underlying this regulation are not yet fully defined, cell cycle-dependent processing of DSBs to generate tracts of ssDNA is likely to have a role, because such structures are required to activate ATR (Jazayeri et al., 2006) . Evidence from both simple eukaryotes and vertebrate cells suggests that Cdk activity is either required for or promotes DNA strand resection (Ira et al., 2004; Deans et al., 2006; Wohlbold and Fisher, 2009; Yata and Esashi, 2009) , providing a potential mechanism for coupling cell cycle progression to checkpoint proficiency and HRR repair. Consistent with this, we observed that the formation of RPAcoated ssDNA also fluctuated during the cell cycle and correlated closely with the pattern of Chk1 activation (Figure 1b) . Several proteins involved in DNA damage response and DNA repair have been identified as Cdk targets in vertebrates, including 53BP1, CtIP, RPA, BRCA1 and BRCA2 (Yata and Esashi, 2009 ). CtIP phosphorylation by Cdk2 has been shown to stimulate interaction with BRCA1 and promote DNA strand resection (Yu et al., 1998) , however, other Cdk targets likely contribute and further work will be required to fully understand the molecular basis for the cell cycle regulation of DNA strand resection and RPA-ssDNA formation.
Interestingly, it was recently reported that Chk1 itself is also a Cdk target (Shiromizu et al., 2006; Ikegami et al., 2008) . During the G2/M transition, Cdk1 phosphorylates Chk1 at Ser286 and Ser301 to promote Chk1 transport from the nucleus to the cytoplasm during prophase and trigger a positive feedback loop that contributes to Cdk1 activation in the nucleus (Kramer et al., 2004; Enomoto et al., 2009) . Subsequent experiments revealed that modification of these sites could also be induced in response to DNA damage or DNA synthesis inhibition, presumably in interphase cells (Ikegami et al., 2008) . As with Cdk1, Cdk2 was shown to have the potential to phosphorylate Chk1 S286/S301 in vitro, however, whether Cdk2 catalyzed these modification in vivo was unclear (Ikegami et al., 2008) .
Here, we have shown that Chk1 S301 phosphorylation is not confined to mitosis but instead increases steadily as cells progress through an unperturbed cell cycle, consistent with the idea that Cdks other than Cdk1 can also catalyze this modification. In addition, using genetically modified Cdk1as, Cdk2-/-and Cdk1as/Cdk2-/-DT40 cells in combination with selective or pan-Cdk inhibitors, we provide evidence that both Cdk1 and Cdk2 can contribute to Chk1 S301 phosphorylation in vivo during an unperturbed cell cycle (Figure 2) .
To test the functional significance of Chk1 S286/S301 phosphorylation for Chk1 activation and function during interphase, we generated a mutant, Chk1 S2A, which can no longer be modified at these sites. Strikingly, ATR-mediated S345 phosphorylation, and thus activation, of the Chk1 S2A mutant protein was greatly impaired after irradiation, as was its ability to restore G2 checkpoint proficiency when stably expressed in Chk1-deficient cells. Despite this, the lower level of irradiation-induced S345 phosphorylation affecting the Chk1 S2A mutant protein was still regulated during the cell cycle (Figures 3a and 4a) .
These observations lead us to propose the following model ( Figure 6 ) in which Cdks regulate DNA damage signaling during the cell cycle at multiple steps. The first step is Cdk2-mediated phosphorylation of CtIP, which stimulates DSB resection and thus determines the strength of ATR activation during the cell cycle (Huertas et al., 2008; Huertas and Jackson, 2009 ). Other Cdk targets might also be involved in DSB resection but the contribution of these is not as clear as for CtIP (Wohlbold and Fisher, 2009; Yata and Esashi, 2009) . The second step is Cdk-mediated phosphorylation of Chk1. Our results indicate that Cdk-mediated phosphorylation of Chk1 determines the overall efficiency of S345 phosphorylation and activation during interphase, but not the cell cycle dependence of this process, which presumably depends on Cdk-and cell cycle-dependent regulation of upstream RPA-ssDNA formation and ATR activation.
This raises the important question of exactly how Cdk-mediated phosphorylation facilitates Chk1 activation during interphase. In contrast to the situation at the G2/M transition, when modification by Cdk1 is thought to promote cytoplasmic translocation (Enomoto et al., 2009) , S301-phosphorylated Chk1 appears to remain predominantly nuclear in interphase cells (Figures 2a  and 4b ) and therefore should be available for activation by ATR. One possibility is that Cdk phosphorylation may induce a conformational change in the Chk1 regulatory domain, thus exposing or 'priming' the adjacent S345 activation site for efficient modification by ATR (Walker et al., 2009) . Interestingly, several lines of evidence suggest that proficiency for ATR activation is either attenuated or switched off immediately before and during mitosis (Shiromizu et al., 2006; Xu et al., 2010) . This could perhaps provide an explanation for why Cdk phosphorylation appears to inhibit Chk1 function during the G2/M transition (Enomoto et al., 2009 ) and yet is required for optimal activation and checkpoint proficiency under conditions of damage. Further work will be required to clarify these issues.
Materials and methods
Cell culture and treatment DT40 B-lymphoma cells were grown in Dulbecco's modified Eagle's medium as described previously (Walker et al., 2009 ), Cdk1as and Cdk1as/Cdk2-/-DT40 cells were grown in RPMI 1640 medium (Gibco/Invitrogen Ltd, Carlsbad, CA, USA) containing 10% fetal bovine serum, 1% chicken serum, 10 À5 M b-mercaptoethanol, penicillin, streptomycin, at 39 1C. To induce DNA damage, cells were irradiated using an Alcyon II CGR MeV Cobalt source as described (Rainey et al., 2008) or treated with etopside (10 mM, Sigma, St Louis, MO, USA), camptothecin (100 mM, Tocris Bioscience, Ellisville, MO, USA) or aphidicolin (20 mM Sigma) as appropriate. To inhibit Cdk1 activity, cells were pretreated with 1NM-PP1 (10 mM, Toronto Research Chemicals, North York, Canada), or roscovitine (25 mM, Calbiochem, San Diego, CA, USA) for 2 h before experimental treatment as appropriate.
Site-directed mutagenesis
The Chk1 S286A S301A mutation was created by site-directed mutagenesis using Quickchange site-directed mutagenesis kit (Stratagene, La Jolla, CA, USA). The primer for S286A mutation is: 5 0 -GTGGTGTCACCGAGGCCCCCGGAGCC CTC-3 0 . The primer for S301A mutation is: 5 0 -CTGACACA GACTTCGCTCCTGTGAAGAGTGCC-3 0 .
Elutriation and EdU labeling DT40 and S2A mutant cells were separated in a Beckman JE-6B elutriating rotor system at room temperature at a constant flow rate of 40 ml/min, and fractions enriched for G1/early S (F1) and late S/G2/M (F2) cells isolated as described previously (Walker et al., 2009) . Where required cells were incubated with 25 mM EdU and subsequently stained using a Click-iT EdU Alexa Fluor 488 Imaging kit (Invitrogen Cat. No. C10337) followed by processing for immunocytochemistry. Images were taken with an Olympus inverted 1 Â 81 confocal microscope (OLYMPUS FV-1000, Tokyo, Japan) or a Nikon A1R confocal microscope (Nikon, Tokyo, Japan) and quantified using Image J software (National Institute of Health, USA, http://rsb.info.nih.gov/ij/).
Immunocytochemistry
For a-pS345 Chk1 staining, cells were fixed in 4% paraformaldehyde in phosphate-buffered saline (PBS) for 15 min followed by permeabilization with 0.5% Triton-X-100 in PBS for 5 min, all at room temperature. For RPA immunocytochemistry, cells were fixed with 4% paraformaldehyde for 15 min, then treated with 70% EtOH/PBS at À20 1C overnight. Fixed preparations were blocked with 3% bovine serum albumin in PBS for 30 min at room temperature, then incubated with primary antibodies for 1 h at room temperature. No. A21429). Images were captured using a Nikon A1R confocal microscope, scale bars on images correspond to 10 mm. The fluorescence intensity of Chk1 pS345 or RPA staining in individual G1, S and G2 phase cells were calculated using Image J software, and the background intensity was subtracted from each image. Absolute units of fluorescence intensity were normalized to untreated G1 phase cells.
Flow cytometry
Cells were fixed in 70% ethanol in PBS overnight. For mitotic index determinations fixed cells were incubated with polyclonal anti-phospho serine 10 histone H3 (pH3) antibodies (Santa Cruz Biotechnology, Santa Cruz, CA, USA, sc-8656) followed by fluorescein isothiocyanate-conjugated secondary antibody (Jackson Labs, Bar Harbor, ME, USA). Cells were then counterstained with propidium iodide and analyzed for Figure 6 Model: Cdks regulate DNA damage processing and Chk1 activation at multiple levels. During interphase Cdk activity contributes to the cell cycle dependence of ATR-Chk1 activation by (i) promoting DNA strand resection at DSBs to form RPAssDNA, a key ATR-activating DNA structure and (ii) via direct phosphorylation of Chk1 at S286 and S301, modifications that facilitate ATR-mediated phosphorylation of Chk1 S345. At the G2/M transition, by contrast, Cdk1-mediated phosphorylation of Chk1 at S286 and S301 forms part of a positive feedback loop that promotes full activation of Cdk1 and mitotic entry. Please refer to the text for additional explanation.
